Terms: = Leukemia AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Clinical Outcome
34 results:
1. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract] [Full Text] [Related]
2. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
Front Immunol; 2019; 10():1625. PubMed ID: 31379830
[TBL] [Abstract] [Full Text] [Related]
3. Association of C3435T, C1236T and C4125A Polymorphisms of the MDR-1 Gene in Egyptian Children with Acute Lymphoblastic Leukaemia.
Talaat RM; Y K El-Kelliny M; El-Akhras BA; Bakry RM; Riad KF; Guirgis AA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2535-2543. PubMed ID: 30256048
[TBL] [Abstract] [Full Text] [Related]
4. Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk leukemias.
Pistoia V; Tumino N; Vacca P; Veneziani I; Moretta A; Locatelli F; Moretta L
Front Immunol; 2018; 9():984. PubMed ID: 29867961
[TBL] [Abstract] [Full Text] [Related]
5. A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.
Tvedt THA; Hovland R; Tsykunova G; Ahmed AB; Gedde-Dahl T; Bruserud Ø
Clin Exp Immunol; 2018 Jul; 193(1):130-141. PubMed ID: 29513361
[TBL] [Abstract] [Full Text] [Related]
6. The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients.
Ćojbašić I; Mačukanović-Golubović L; Mihailović D; Vučić M; Ćojbašić Ž
Pol J Pathol; 2017; 68(3):241-251. PubMed ID: 29363916
[TBL] [Abstract] [Full Text] [Related]
7. Perforin gene variation influences survival in childhood acute lymphoblastic leukemia.
Jaworowska A; Pastorczak A; Trelinska J; Wypyszczak K; Borowiec M; Fendler W; Sedek L; Szczepanski T; Ploski R; Młynarski W
Leuk Res; 2018 Feb; 65():29-33. PubMed ID: 29304394
[TBL] [Abstract] [Full Text] [Related]
8. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute leukemia Working Party of the EBMT.
Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
[TBL] [Abstract] [Full Text] [Related]
9. Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Todisco E; Ciceri F; Boschini C; Giglio F; Bacigalupo A; Patriarca F; Donnini I; Alessandrino EP; Arcese W; Iori AP; Marenco P; Cavattoni I; Chiusolo P; Terruzzi E; Castagna L; Santoro A; Bosi A; Oldani E; Bruno B; Bonifazi F; Rambaldi A
Bone Marrow Transplant; 2017 Jul; 52(7):955-961. PubMed ID: 28067875
[TBL] [Abstract] [Full Text] [Related]
10. Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia.
Jang W; Yoon JH; Park J; Lee GD; Kim J; Kwon A; Choi H; Han K; Nahm CH; Kim HJ; Min WS; Kim M; Kim Y
Blood Cancer J; 2016 Jan; 6(1):e387. PubMed ID: 26771813
[TBL] [Abstract] [Full Text] [Related]
11. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid leukemia and Influence on clinical outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract] [Full Text] [Related]
12. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
[TBL] [Abstract] [Full Text] [Related]
13. Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.
Palandri F; Latagliata R; Polverelli N; Tieghi A; Crugnola M; Martino B; Perricone M; Breccia M; Ottaviani E; Testoni N; Merli F; Aversa F; Alimena G; Cavo M; Martinelli G; Catani L; Baccarani M; Vianelli N
Leukemia; 2015 Jun; 29(6):1344-9. PubMed ID: 25801912
[TBL] [Abstract] [Full Text] [Related]
14. Improved prediction of clinical outcome in chronic myeloid leukemia.
Ćojbašić I; Mačukanović-Golubović L; Mihailović D; Vučić M; Lukić S
Int J Hematol; 2015 Feb; 101(2):173-83. PubMed ID: 25540066
[TBL] [Abstract] [Full Text] [Related]
15. Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia.
Wang H; Cao F; Li J; Li Y; Liu X; Wang L; Liu Z; Li Y; Zhao H; Zhou J
Int J Hematol; 2014 Aug; 100(2):165-70. PubMed ID: 24929848
[TBL] [Abstract] [Full Text] [Related]
16. Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.
Rambaldi A; Biagi E; Bonini C; Biondi A; Introna M
Leukemia; 2015 Jan; 29(1):1-10. PubMed ID: 24919807
[TBL] [Abstract] [Full Text] [Related]
17. BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Moore AS; Alonzo TA; Gerbing RB; Lange BJ; Heerema NA; Franklin J; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2014 Apr; 61(4):647-52. PubMed ID: 24127439
[TBL] [Abstract] [Full Text] [Related]
18. Acquisition of a BCR-ABL1 transcript in a patient with disease progression from MDS with fibrosis to AML with myelodysplasia-related changes.
Park SJ; Lee HW; Jeong SH; Park JS; Kim HC; Seok JY; Kim HJ; Cho SR
Ann Clin Lab Sci; 2011; 41(4):379-84. PubMed ID: 22166509
[TBL] [Abstract] [Full Text] [Related]
19. minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation.
Lio HY; Tang JL; Wu J; Wu SJ; Lin CY; Yang YC
Clin Chem Lab Med; 2010 Sep; 48(9):1287-93. PubMed ID: 20509834
[TBL] [Abstract] [Full Text] [Related]
20. minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
[TBL] [Abstract] [Full Text] [Related]
[Next]
